by National Institutes of Health A new study provides evidence to support a simple measurement for diagnosing clinically significant airflow obstruction, the key characteristic of chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States. The study found that a 70% ratio of two indicators of lung function proved as or more accurate than other thresholds for...
Tag: <span>COPD</span>
Post
New risk scores help physicians provide better care for high-risk pulmonary patients, study finds
INTERMOUNTAIN MEDICAL CENTER A new laboratory-based method of estimating outcomes for patients with a severe pulmonary disorder that has no cure can help physicians better provide proper care, referrals, and services for patients at the end of life, according to a new study of more than 17,000 patients from Intermountain Healthcare. The Laboratory-based Intermountain Validated Exacerbation (LIVE) score is a prediction model that predicts all-cause mortality, morbidity, and hospitalization rates for patients with chronic obstructive pulmonary disease (COPD),...
Post
COPD may strike women harder than men
by Steven Reinberg, Healthday Reporter Smoking is its leading cause, and while women report smoking less than men, those with COPD have more trouble breathing, more frequent flare-ups and a poorer quality of life, researchers found. “Physicians need to be aware that symptoms for women may be worse for a given level of lung function and that exacerbations may be more frequent,”...
Post
Azithromycin appears to reduce treatment failure in severe, acute COPD exacerbations
AMERICAN THORACIC SOCIETY May 3, 2019–The antibiotic azithromycin may reduce treatment failure in patients hospitalized for an acute exacerbation of chronic obstructive pulmonary disease(COPD), according to a randomized, controlled trial published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Azithromycin during Acute COPD Exacerbations Requiring Hospitalization (BACE): a Multicenter, Randomized, Double-blind, Placebo-controlled Trial,” researchers in...
Post
Common lung conditions linked to heart disease
Patients with some of the most common lung diseases are substantially more likely to suffer a heart attack and develop other major heart problems according to new research. The team of heart and lung doctors from the University of Manchester and Aston Medical School found people with asthma, chronic obstructive pulmonary disease (COPD) and lung fibrosis, were more likely to develop, and die from, heart disease and heart failure. The study of nearly 100,000 people with lung disease in...
Post
Non-invasive imaging technique valid for identifying small airway disease in lung
Discovery holds promise for developing urgently needed new therapies in COPD MICHIGAN MEDICINE – UNIVERSITY OF MICHIGAN Chronic obstructive pulmonary disease (COPD), an inflammatory disease of the small airways in the lungs, affects 16 million Americans and is the fourth leading cause of death in the United States, according to the National Heart Lung and Blood Institute (NHLBI). Identifying small airway disease in its earliest stages, when it...
Post
Raising awareness of lung cancer risk in people with COPD
During this unique study, led by the University of Glasgow and University of Surrey, researchers investigated how the experience of COPD, influences how individuals understand new or changing chest symptoms and their decision to seek help from medical professionals. COPD is the name for a group of lung conditions, including emphysema and chronic bronchitis, which...
Post
Raising awareness of lung cancer risk in people with COPD
People with chronic obstructive pulmonary disease (COPD) need more support when understanding and acting on new chest symptoms, a study in the journal Psycho-Oncologyreports. Credit: CC0 Public Domain During this unique study, led by the University of Glasgow and University of Surrey, researchers investigated how the experience of COPD, influences how individuals understand new or...
Post
Flu shot crucial for those with COPD
(HealthDay)—If you suffer from chronic obstructive pulmonary disease (COPD), a flu shot can be a lifesaver. But many of the millions with the lung condition don’t get it, researchers report. COPD causes inflammation in the lungs and it can flare up when triggered by the flu, making the infection worse, explained lead researcher Dr. Sunita Mulpuru. She is an associate...
Post
Teva’s ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment
Teva Pharmaceutical, based in Israel, landed the first FDA approval for a digital inhaler with built-in sensors. The ProAir Digihaler (albuterol sulfate 117 mcg) Inhalation Powder is indicated for people suffering from asthma & COPD as a way of preventing and treating bronchospasm, a tightening of the muscles that line the airways. The ProAir Digihaler...